We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
-3.48%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$85.2B
AUM Growth
+$4.83B
Cap. Flow
+$8.98B
Cap. Flow %
10.54%
Top 10 Hldgs %
12.02%
Holding
4,686
New
822
Increased
1,556
Reduced
1,625
Closed
650

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$786M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$409M
3
MU icon
Micron Technology
MU
+$379M
4
T icon
AT&T
T
+$372M
5
MDT icon
Medtronic
MDT
+$370M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Technology 14.95%
3 Consumer Discretionary 11.34%
4 Consumer Staples 10.7%
5 Communication Services 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGTC
3751
DELISTED
Applied Genetic Technologies Corporation
AGTC
$127K ﹤0.01%
118,840
+30,000
+34% +$54.5K
AMBO
3752
Ambow Education Holding
AMBO
$5.89M
$126K ﹤0.01%
16,412
+160
+1% +$1.21K
CASI
3753
DELISTED
CASI Pharmaceuticals
CASI
$126K ﹤0.01%
15,530
-130,277
-89% -$1.02M
SXTC icon
3754
China SXT Pharmaceuticals
SXTC
$1.76M
0
AXLA
3755
DELISTED
Axcella Health Inc. Common Stock
AXLA
$126K ﹤0.01%
1,956
+92
+5% +$4.59K
FRMM
3756
Forum Markets
FRMM
$81.8M
$125K ﹤0.01%
+13
New +$149K
NURO
3757
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$125K ﹤0.01%
3,766
-14,326
-79% -$510K
ASC icon
3758
Ardmore Shipping
ASC
$681M
$124K ﹤0.01%
27,500
+9,000
+49% +$35.3K
SYBX
3759
DELISTED
Synlogic
SYBX
$123K ﹤0.01%
3,420
-227
-6% -$7.07K
JNCE
3760
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$123K ﹤0.01%
+18,100
New +$129K
FINV
3761
FinVolution Group
FINV
$1.07B
$121K ﹤0.01%
+30,500
New +$127K
SANW
3762
DELISTED
S&W Seed Co
SANW
$121K ﹤0.01%
2,980
-963
-24% -$42.2K
USAS
3763
Americas Gold and Silver
USAS
$1.75B
$121K ﹤0.01%
+44,840
New +$107K
NABL icon
3764
N-able
NABL
$695M
$120K ﹤0.01%
+13,200
New +$139K
WKEY
3765
WISeKey
WKEY
$82.2M
$119K ﹤0.01%
9,300
+5,600
+151% +$91.4K
PHAS
3766
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$118K ﹤0.01%
+89,300
New +$145K
CDAK
3767
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$116K ﹤0.01%
+18,500
New +$116K
BLRX
3768
BioLineRX
BLRX
$11.7M
$115K ﹤0.01%
1,684
+1,331
+377% +$92.7K
VIOT
3769
Viomi Technology
VIOT
$48M
$115K ﹤0.01%
65,864
+22,100
+50% +$43K
MYSZ icon
3770
My Size
MYSZ
$281K
$114K ﹤0.01%
206
-111
-35% -$67.4K
OXBR icon
3771
Oxbridge Re Holdings
OXBR
$10.5M
$114K ﹤0.01%
20,882
-9,118
-30% -$52K
MEC icon
3772
Mayville Engineering Co
MEC
$596M
$113K ﹤0.01%
12,100
-23,500
-66% -$267K
PAVS icon
3773
Paranovus Entertainment Technology
PAVS
$5.71M
0
TRDA icon
3774
Entrada Therapeutics
TRDA
$299M
$111K ﹤0.01%
11,800
-1,773
-13% -$19K
IMG
3775
DELISTED
CIMG Inc
IMG
$111K ﹤0.01%
+72
New +$127K

Similar funds

Jim Simons's Q1 2022 Portfolio in Review

As of Q1 2022, Jim Simons held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.

  • Jim Simons's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
  • Jim Simons added most to Tesla in Q1 2022, an estimated $759M increase.
  • Jim Simons's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
  • Jim Simons fully exited Microsoft in Q1 2022, selling an estimated $786M.
  • Jim Simons's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
  • Jim Simons opened 822 new positions and closed 650 in Q1 2022.
  • Jim Simons's portfolio value rose 6% quarter-over-quarter to $85.2B.

Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.